Group 1: Stock Performance - Comcast's stock closed at $36.09, showing a +0.22% change from the previous day's closing price, underperforming the S&P 500's daily gain of 1.08% [1] - Over the past month, Comcast shares have decreased by 0.94%, outperforming the Consumer Discretionary sector's decline of 10.47% and the S&P 500's loss of 8.26% [1] Group 2: Earnings Expectations - Comcast is set to release its earnings on April 24, 2025, with an expected EPS of $1.01, reflecting a 2.88% decrease from the same quarter last year [2] - The consensus estimate for revenue is $29.86 billion, indicating a 0.66% decrease compared to the previous year [2] Group 3: Annual Estimates - For the annual period, the Zacks Consensus Estimates project earnings of $4.35 per share and revenue of $122.86 billion, representing changes of +0.46% and -0.7% respectively from the last year [3] - Recent changes to analyst estimates for Comcast may indicate shifting business dynamics, with positive revisions suggesting analysts' confidence in the company's performance [3][4] Group 4: Zacks Rank and Valuation - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Comcast at 3 (Hold) [5] - Comcast's Forward P/E ratio is 8.27, which is lower than the industry average of 8.41, and its PEG ratio stands at 1.75, compared to the industry average of 1.14 [6] Group 5: Industry Context - The Cable Television industry, part of the Consumer Discretionary sector, holds a Zacks Industry Rank of 178, placing it in the bottom 30% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Goldman Sachs closed at $551.78, with a slight increase of +0.08% from the previous session, outperforming the S&P 500 which fell by 1.07% [1] - Over the last month, Goldman Sachs shares decreased by 16.53%, underperforming the Finance sector's loss of 3.42% and the S&P 500's loss of 7.03% [1] Upcoming Earnings - The upcoming earnings disclosure is anticipated, with an expected EPS of $12.55, reflecting an 8.38% increase from the same quarter last year [2] - Revenue is projected at $15.28 billion, indicating a 7.5% rise from the previous year [2] Full Year Projections - For the full year, earnings are estimated at $46.80 per share and revenue at $57.35 billion, representing increases of +15.44% and +7.18% respectively from the prior year [3] Analyst Projections - Recent shifts in analyst projections for Goldman Sachs should be monitored, as positive revisions indicate optimism about the company's business and profitability [4] Stock Performance and Rankings - The Zacks Rank system, which assesses estimate changes, currently ranks Goldman Sachs at 3 (Hold), with a recent downward shift of 0.67% in the EPS estimate [6] - The Zacks Rank has a historical average annual return of +25% for 1 ranked stocks since 1988 [6] Valuation Metrics - Goldman Sachs has a Forward P/E ratio of 11.78, which is below the industry's average Forward P/E of 13.9, indicating a valuation discount [7] - The PEG ratio for Goldman Sachs is 0.77, compared to the Financial - Investment Bank industry's average PEG ratio of 1.06 [7] Industry Context - The Financial - Investment Bank industry is part of the Finance sector and holds a Zacks Industry Rank of 20, placing it in the top 8% of over 250 industries [8] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the strength of the industry [8]

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics and fundamental ...

Lockheed Martin (LMT) ended the recent trading session at $467.61, demonstrating a +0.31% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.64%. Elsewhere, the Dow saw an upswing of 0.85%, while the tech-heavy Nasdaq appreciated by 0.31%.Heading into today, shares of the aerospace and defense company had gained 10.16% over the past month, outpacing the Aerospace sector's gain of 1.09% and the S&P 500's loss of 7.69% in that time.The upcoming earnings release of Loc ...

Group 1 - Axon Enterprise's stock closed at $554.39, reflecting a -0.34% change from the previous day, underperforming compared to the S&P 500's gain of 0.64% [1] - The stock has decreased by 18.61% over the past month, contrasting with the Aerospace sector's gain of 1.09% and the S&P 500's loss of 7.69% [1] Group 2 - The upcoming earnings release is anticipated, with projected EPS at $1.34, indicating a 16.52% increase year-over-year, and revenue forecasted at $587.76 million, representing a 27.57% growth [2] - For the fiscal year, earnings are projected at $6.38 per share and revenue at $2.61 billion, reflecting increases of +7.41% and +25.15% respectively from the prior year [3] Group 3 - Recent adjustments to analyst estimates for Axon Enterprise are noteworthy, as positive revisions indicate analysts' confidence in the company's performance and profit potential [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Axon Enterprise at 3 (Hold), with a significant downward shift of 86.81% in the EPS estimate over the past month [6] Group 4 - Axon Enterprise's Forward P/E ratio stands at 87.23, significantly higher than the industry's average Forward P/E of 29.73, indicating a premium valuation [7] - The company has a PEG ratio of 3.14, compared to the Aerospace - Defense Equipment industry's average PEG ratio of 2.45, suggesting higher anticipated earnings growth relative to its peers [8] Group 5 - The Aerospace - Defense Equipment industry, which includes Axon Enterprise, has a Zacks Industry Rank of 34, placing it in the top 14% of over 250 industries, indicating strong performance potential [8][9]

Company Performance - Chipotle Mexican Grill (CMG) closed at $49.65, down 0.76% from the previous trading day, underperforming the S&P 500 which gained 0.64% [1] - Over the past month, CMG shares have decreased by 12.35%, compared to the Retail-Wholesale sector's loss of 11.57% and the S&P 500's loss of 7.69% [1] Earnings Expectations - Analysts expect Chipotle to report earnings of $0.29 per share, reflecting a year-over-year growth of 7.41% [2] - The Zacks Consensus Estimate for revenue is projected at $2.97 billion, an increase of 9.89% from the previous year [2] Full Year Projections - For the full year, earnings are projected at $1.29 per share and revenue at $12.62 billion, indicating changes of +15.18% and +11.52% respectively from the prior year [3] Analyst Sentiment - Recent shifts in analyst projections for Chipotle are important as they reflect short-term business trends, with positive revisions indicating optimism regarding the company's profitability [4] - The Zacks Rank system, which incorporates these estimate changes, currently rates Chipotle at 3 (Hold) [6] Valuation Metrics - Chipotle's Forward P/E ratio stands at 38.93, which is a premium compared to the industry's average Forward P/E of 22.82 [7] - The company has a PEG ratio of 1.93, while the Retail - Restaurants industry has an average PEG ratio of 2.07 [7] Industry Context - The Retail - Restaurants industry is part of the Retail-Wholesale sector and currently holds a Zacks Industry Rank of 127, placing it in the top 50% of over 250 industries [8] - Research indicates that top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Intel closed at $24.05, reflecting a +1.48% change, which lagged behind the S&P 500's gain of 2.13% [1] - The stock has decreased by 1.78% over the past month, contributing to a 13.29% loss in the Computer and Technology sector and a 9.57% loss in the S&P 500 [1] Earnings Forecast - Intel is expected to report an EPS of $0, indicating a 100% decline from the same quarter last year [2] - Revenue is forecasted at $12.28 billion, representing a 3.51% decrease compared to the previous year [2] Full Year Projections - For the full year, earnings are projected at $0.48 per share and revenue at $53.36 billion, reflecting increases of +469.23% and +0.48% respectively from the prior year [3] - Recent analyst estimate revisions indicate changing business trends, with positive revisions suggesting optimism about Intel's profitability [3][4] Valuation Metrics - Intel's Forward P/E ratio stands at 49.5, significantly higher than the industry average of 28.12, indicating a premium valuation [6] - The PEG ratio for Intel is currently 2.92, compared to the industry average of 1.92, suggesting higher expected earnings growth relative to its price [6] Industry Context - The Semiconductor - General industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 33, placing it in the top 14% of over 250 industries [7] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Allstate's stock has shown resilience in the market, outperforming major indices despite a forecasted decline in earnings per share (EPS) for the upcoming quarter while revenue is expected to increase. Group 1: Stock Performance - Allstate's stock closed at $202, reflecting a +1.89% change from the previous trading day's close, outperforming the S&P 500, which fell by 0.91% [1] - Over the past month, Allstate shares gained 4.71%, contrasting with the Finance sector's loss of 5.01% and the S&P 500's loss of 7.38% [1] Group 2: Earnings Forecast - Allstate is projected to report an EPS of $3.98, representing a 22.42% decrease from the same quarter last year [2] - Revenue is expected to reach $17.13 billion, indicating an 11.04% increase compared to the previous year [2] Group 3: Annual Estimates - For the entire year, earnings are forecasted at $18.62 per share and revenue at $69.64 billion, reflecting changes of +1.64% and +8.26% respectively compared to the previous year [3] Group 4: Analyst Estimates - Recent changes in analyst estimates suggest a favorable outlook on Allstate's business health and profitability [4] - The Zacks Consensus EPS estimate has shifted 1.01% downward over the past month, and Allstate currently holds a Zacks Rank of 3 (Hold) [6] Group 5: Valuation Metrics - Allstate has a Forward P/E ratio of 10.65, which is lower than the industry's average Forward P/E of 11.47, indicating a valuation discount [6] - The company has a PEG ratio of 1.08, compared to the industry average PEG ratio of 1.68, suggesting a more favorable growth outlook relative to its valuation [7] Group 6: Industry Context - The Insurance - Property and Casualty industry, part of the Finance sector, holds a Zacks Industry Rank of 34, placing it in the top 14% of over 250 industries [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1, indicating a strong competitive position for Allstate within its industry [8]

Company Performance - Luminar Technologies, Inc. closed at $5.17, reflecting a -1.9% change from the previous day, which is less than the S&P 500's daily loss of 1.78% [1] - Over the past month, shares of Luminar experienced a loss of 2.95%, outperforming the Auto-Tires-Trucks sector's loss of 15.76% and the S&P 500's loss of 3.48% [1] Upcoming Earnings Report - The company is set to release its earnings on March 20, 2025, with an expected EPS of -$2.20, indicating a 26.67% growth compared to the same quarter last year [2] - The consensus estimate for revenue is $16.76 million, which represents a 24.2% decrease compared to the previous year [2] Analyst Estimates and Rankings - Recent modifications to analyst estimates for Luminar Technologies are crucial as they reflect changing business trends, with positive revisions indicating analyst optimism [3] - The Zacks Rank system, which evaluates estimate changes, currently places Luminar Technologies at a rank of 3 (Hold) [5] - The Zacks Consensus EPS estimate has remained stagnant over the past month [5] Industry Context - Luminar Technologies operates within the Automotive - Original Equipment industry, which ranks 157th in the Zacks Industry Rank, placing it in the bottom 38% of over 250 industries [6] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6]

Company Performance - Bristol Myers Squibb (BMY) closed at $60.18, with a daily increase of +0.6%, outperforming the S&P 500's loss of 1.78% [1] - Over the past month, BMY shares gained 0.18%, while the Medical sector increased by 0.26% and the S&P 500 decreased by 3.48% [1] Financial Projections - The upcoming earnings per share (EPS) for Bristol Myers Squibb is projected at $1.55, representing a significant increase of 135.23% from the same quarter last year [2] - Revenue is estimated to be $10.69 billion, reflecting a decline of 9.94% compared to the equivalent quarter last year [2] Annual Estimates - For the entire year, earnings are forecasted at $6.75 per share, indicating a remarkable increase of 486.96%, while revenue is projected at $45.59 billion, showing a decrease of 5.6% compared to the previous year [3] Analyst Sentiment - Recent changes to analyst estimates for Bristol Myers Squibb reflect evolving short-term business trends, with positive revisions indicating analyst optimism about the company's profitability [3][4] Zacks Rank and Performance - The Zacks Rank system, which evaluates estimate changes, currently ranks Bristol Myers Squibb at 3 (Hold), with the consensus EPS estimate moving 3.96% lower over the last 30 days [5] - Historically, 1 ranked stocks in the Zacks Rank system have yielded an average annual return of +25% since 1988 [5] Valuation Metrics - Bristol Myers Squibb has a Forward P/E ratio of 8.87, indicating a discount compared to its industry's Forward P/E of 19.4 [6] - The company has a PEG ratio of 2.22, while the Medical - Biomedical and Genetics industry has an average PEG ratio of 1.57 [7] Industry Context - The Medical - Biomedical and Genetics industry, part of the Medical sector, holds a Zacks Industry Rank of 66, placing it in the top 27% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]